StockDriftsStockDriftsBC World Pharmaceutical (200780) has 2 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩40M ($28K) in reported transaction value. The earliest filing StockDrifts holds for BC World Pharmaceutical is dated 2024-12-20; the most recent is 2026-03-31. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +34.55%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | SELL | 임원퇴임 | 이승철 Seungcheol Lee | standing advisor | -60.4K | ₩4,545 | -1.1% | ₩274M ($191K) |
| 2026-03-26 | BUY | 주식배당 | 이승철 Seungcheol Lee | standing advisor | 5.5K | ₩4,865 | -0.9% | ₩27M ($19K) |
| 2026-03-26 | BUY | 주식배당 | 장태억 Jang Tae-eok | vice president | 1.5K | ₩4,865 | -0.9% | ₩7M ($5K) |
| 2026-03-26 | BUY | 주식배당 | 홍영기 Youngki Hong | vice president | 121.7K | ₩4,865 | -0.9% | ₩592M ($411K) |
| 2026-03-26 | BUY | 주식배당 | 홍성한 Hong Seong-han | CEO | 196.2K | ₩4,865 | -0.9% | ₩955M ($663K) |
| 2025-12-08 | BUY | 수증 | 홍영기 Youngki Hong | vice president | 1.0M | ₩4,249 | +27.1% | ₩4.2B ($3.0M) |
| 2025-12-08 | SELL | 증여 | 홍성한 Hong Seong-han | CEO | -1.4M | ₩4,249 | -27.1% | ₩5.7B ($4.0M) |
| 2025-03-28 | BUY | 주식배당 | 장태억 Jang Tae-eok | vice president | 1.4K | ₩3,984 | +35.5% | ₩5M ($4K) |
| 2025-03-28 | BUY | 주식배당 | 홍성한 Hong Seong-han | CEO | 301.1K | ₩3,984 | +35.5% | ₩1.2B ($833K) |
| 2025-03-28 | BUY | 주식배당 | 홍영기 Youngki Hong | vice president | 19.7K | ₩3,984 | +35.5% | ₩79M ($55K) |
| 2025-03-28 | BUY | 주식배당 | 이승철 Seungcheol Lee | standing advisor | 5.0K | ₩3,984 | +35.5% | ₩20M ($14K) |
| 2024-12-23 | BUY | Market Buy | 홍영기 Youngki Hong | Managing Director | 5.1K | ₩4,024 | +34.2% | ₩20M ($14K) |
| 2024-12-20 | BUY | Market Buy | 홍영기 Youngki Hong | Managing Director | 4.9K | ₩4,003 | +34.9% | ₩20M ($14K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for BC World Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.